/ /

Beth H. Karlan, MD
Dr. Karlan is Associate Professor of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, and Director, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, Calif., where she also holds the Board of Governors' Endowed Chair in Gynecologic Oncology.
BRCA1 and BRCA2: Genetic testing and intervention strategies
Who should undergo genetic testing? Before ordering it, three conditions should be met: There should be a greater than 10% likelihood of a positive test; the ordering physician should be able to interpret the result; and the information should be used to make management decisions.